Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 5Squamous Cell Carcinoma of Head and Neck 3Carcinoma, Non-Small-Cell Lung 3Urinary Bladder Neoplasms 2Salivary Gland Neoplasms 2Prostatic Neoplasms 2Oropharyngeal Neoplasms 2Mouth Neoplasms 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2Gliosarcoma 2Glioblastoma 2Colorectal Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma 2Breast Neoplasms 2Urogenital Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Rare Diseases 1Pancreatic Neoplasms 1Oligodendroglioma 1Meningioma 1Melanoma 1Lung Neoplasms 1Head and Neck Neoplasms 1Glioma 1Genetic Diseases, Inborn 1Carcinoma, Renal Cell 1Carcinoma, Merkel Cell 1

Interventions

Melphalan 3sargramostim 1romidepsin 1montanide ISA 51 1keyhole-limpet hemocyanin 1detox adjuvant 1Waiting Lists 1Thalidomide 1Radiosurgery 1Radiation 1Leucovorin 1Ketoconazole 1Interleukin-2 1Floxuridine 1FANG vaccine 1Docetaxel 1Alendronate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Genetic Diseases, Inborn × Radiosurgery × Clear all
NCT00004659 2005-06-24

Phase II Randomized Study of Stereotactic Radiosurgery Plus Fractionated Whole-Brain Radiotherapy Vs Fractionated Whole-Brain Radiotherapy Alone for Multiple Primary or Metastatic Brain Tumors

Office of Rare Diseases (ORD)

Phase 2 Unknown
40 enrolled
CNS

Brain Neoplasms, Genetic Diseases, Inborn, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡